Clinical Trial Update: Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation [Phase 1]

View source ↗

Summary

A Phase 1 Mayo Clinic trial evaluating whether adding mangosteen juice to usual care affects the risk of recurrent atrial fibrillation; the study status is term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Mangosteen juice

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | Phase 1 | Status: TERMINATED